In a cross-sectional multicenter study, CSF neurogranin levels were significantly greater in Alzheimer’s disease patients compared with subjects with frontotemporal dementia and healthy controls with normal cognitive function [283]. This evidence concerns the gene NRGN and Alzheimer disease.